Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women
- PMID: 7488894
- PMCID: PMC2551115
- DOI: 10.1136/bmj.311.7014.1193
Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women
Abstract
Objectives: To examine the association between androstenedione, total and bioavailable testosterone, oestrone, and total and bioavailable oestradiol concentrations and the risk of death from cardiovascular and ischaemic heart disease.
Design: 19 year old population based prospective study with 99.9% follow up.
Setting: Rancho Bernardo, California.
Subjects: 651 postmenopausal women, none taking oestrogen.
Main outcome measures: Concentrations of plasma sex hormones measured by radioimmunoassay in an endocrinology research laboratory. Cardiovascular and ischaemic heart disease deaths assessed by death certificate; 85% of 30% sample validated by record review.
Results: Age adjusted concentrations of sex hormones did not differ significantly in women with and without a history of heart disease at baseline and did not predict cardiovascular death or death from ischaemic heart disease. Most 95% confidence intervals for the age adjusted relative risk of cardiovascular death or death from ischaemic heart disease were narrow, and all included one. Endogenous oestrogen concentrations were not associated with significantly more favourable risk factors for heart disease, and testosterone was not associated with less favourable risk factors.
Conclusion: These prospective data do not support a causal or preventive role for endogenous oestrogens or androgens and cardiovascular mortality in older women.
Comment in
-
Endogenous sex hormones and cardiovascular disease in postmenopausal women. Other sources of variability should have been taken into account.BMJ. 1996 Mar 23;312(7033):777. doi: 10.1136/bmj.312.7033.777. BMJ. 1996. PMID: 8605483 Free PMC article. No abstract available.
Similar articles
-
Extreme concentrations of endogenous sex hormones, ischemic heart disease, and death in women.Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):471-7. doi: 10.1161/ATVBAHA.114.304821. Epub 2014 Dec 30. Arterioscler Thromb Vasc Biol. 2015. PMID: 25550203
-
Endogenous oestradiol as a positive correlate of plasma fibrinogen among older postmenopausal women: a population-based study (the Three-City cohort study).Clin Endocrinol (Oxf). 2012 Dec;77(6):905-10. doi: 10.1111/j.1365-2265.2012.04448.x. Clin Endocrinol (Oxf). 2012. PMID: 22642405
-
Total but not bioavailable testosterone is a predictor of central adiposity in postmenopausal women.Int J Obes Relat Metab Disord. 1995 May;19(5):293-8. Int J Obes Relat Metab Disord. 1995. PMID: 7647819
-
Testosterone and the heart: friend or foe?Climacteric. 2024 Feb;27(1):53-59. doi: 10.1080/13697137.2023.2250252. Epub 2023 Sep 4. Climacteric. 2024. PMID: 37666273 Review.
-
Cardiovascular disease in postmenopausal women.Maturitas. 1998 Sep 20;30(1):11-8. doi: 10.1016/s0378-5122(98)00054-1. Maturitas. 1998. PMID: 9819778 Review.
Cited by
-
A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: results from the National Institutes of Health/National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).Am Heart J. 2010 Jun;159(6):987.e1-7. doi: 10.1016/j.ahj.2010.03.024. Am Heart J. 2010. PMID: 20569710 Free PMC article. Clinical Trial.
-
Prospective study of endogenous circulating estradiol and risk of stroke in older women.Arch Neurol. 2010 Feb;67(2):195-201. doi: 10.1001/archneurol.2009.322. Arch Neurol. 2010. PMID: 20142527 Free PMC article.
-
Endogenous sex hormones and cardiovascular disease in postmenopausal women: new but conflicting data.Ann Transl Med. 2018 Dec;6(23):448. doi: 10.21037/atm.2018.11.18. Ann Transl Med. 2018. PMID: 30603636 Free PMC article. No abstract available.
-
Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation.J Clin Endocrinol Metab. 2008 Apr;93(4):1276-84. doi: 10.1210/jc.2007-0425. Epub 2008 Jan 8. J Clin Endocrinol Metab. 2008. Retraction in: J Clin Endocrinol Metab. 2015 Mar;100(3):1206. doi: 10.1210/jc.2014-4415 PMID: 18182456 Free PMC article. Retracted.
-
Low free testosterone levels are associated with all-cause and cardiovascular mortality in postmenopausal diabetic women.Diabetes Care. 2011 Aug;34(8):1771-7. doi: 10.2337/dc11-0596. Epub 2011 Jun 29. Diabetes Care. 2011. PMID: 21715525 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources